Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 17/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 10/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.56 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 13/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14918038 | 0.93 | HDAC6 (0.58) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL14918678 | 0.90 | HDAC6 (0.54) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL14918708 | 0.90 | HDAC6 (0.49) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL14918826 | 0.88 | HDAC6 (0.59) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL14918527 | 0.85 | HDAC6 (0.49) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL14918501 | 0.85 | HDAC6 (0.48) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL14918764 | 0.85 | HDAC6 (0.52) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL14918962 | 0.84 | HDAC6 (0.52) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL14918378 | 0.84 | HDAC6 (0.47) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL14918437 | 0.83 | HDAC6 (0.50) | HDAC6HDAC1HDAC8HDAC5HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013066835-A2 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |